Cargando…

The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer

BACKGROUND: Immune checkpoint inhibitors have aroused great expectation of tumor eradication. However, the effect of anti-PD-L1 treatment for cervical cancer is unsatisfactory and the underlying antagonist to anti-PD-L1 efficacy is remained to be studied. Here, we investigated the anti-tumor effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fengying, Zhang, Fengying, Wang, Qian, Xu, Ying, Xu, Shuifang, Zhang, Caihong, Wang, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414724/ https://www.ncbi.nlm.nih.gov/pubmed/34479503 http://dx.doi.org/10.1186/s12865-021-00451-7

Ejemplares similares

Closer to a Uniform Language in Colposcopy: Study on the Potential Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology in Clinical Practice
por: Li, Yanyun, et al.
Publicado: (2017)

Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression
por: He, Yuhua, et al.
Publicado: (2021)

Risk undermined in the bilateral pharmaceutical regulatory system in Taiwan
por: Wang, Hui-Po, et al.
Publicado: (2018)

Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells
por: Wang, Shijia, et al.
Publicado: (2020)

LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer
por: Xu, Shengjie, et al.
Publicado: (2021)

Synchronous ground‐glass nodules showed limited response to anti‐PD‐1/PD‐L1 therapy in patients with advanced lung adenocarcinoma
por: Wu, Fengying, et al.
Publicado: (2020)

Siomycin A induces reactive oxygen species-mediated cytotoxicity in ovarian cancer cells
por: Shao, Xiulan, et al.
Publicado: (2021)

Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy
por: Hu, Jianjun, et al.
Publicado: (2022)

PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer
por: Zhang, Hanqun, et al.
Publicado: (2022)

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
por: Xu, Yiqi, et al.
Publicado: (2021)

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Mediating effects of meaning in life on the relationship between general self-efficacy and nursing professional commitment in nursing students: A structural equation modeling approach
por: Cheng, Linan, et al.
Publicado: (2021)

Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review
por: Zhang, Yiru, et al.
Publicado: (2023)

The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
por: Liang, Leilei, et al.
Publicado: (2018)

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
por: Zhang, Wenxin, et al.
Publicado: (2023)

Natural capital investments in China undermined by reclamation for cropland
por: Kong, Lingqiao, et al.
Publicado: (2023)

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
por: Qian, Jiawen, et al.
Publicado: (2018)

The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer
por: Sheng, Zhixin, et al.
Publicado: (2017)

Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
por: Jiang, Siqing, et al.
Publicado: (2022)

CPI‐203 improves the efficacy of anti‐PD‐1 therapy by inhibiting the induced PD‐L1 overexpression in liver cancer
por: Niu, Xiaoge, et al.
Publicado: (2021)

A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis
por: Yu, Ziyang, et al.
Publicado: (2022)

Impacts of Urbanization Undermine Nestedness of the Plant–Arbuscular Mycorrhizal Fungal Network
por: Lin, Litao, et al.
Publicado: (2021)

Undermining the Tower of Babel
Publicado: (1970)

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
por: Qi, Yihang, et al.
Publicado: (2021)

Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
por: Zhang, Fei, et al.
Publicado: (2017)

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC
por: Liu, Sangtian, et al.
Publicado: (2021)

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
por: Gao, Yang, et al.
Publicado: (2020)

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases
por: Sun, Chenglong, et al.
Publicado: (2020)

Safety and Efficacy of PD-1/PD-L1 Inhibitors in Cancer Patients With Preexisting Autoantibodies
por: Tang, Hui, et al.
Publicado: (2022)

The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge
por: Li, Chen, et al.
Publicado: (2023)

Prospects of the potential strategies to improve the efficacy of anti‐PD‐1/PD‐L1 therapy
por: Yamaguchi, Hirohito, et al.
Publicado: (2022)

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
por: Chen, Jiming, et al.
Publicado: (2022)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy
por: Liu, Junjie, et al.
Publicado: (2022)

The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma
por: Zeng, Hui, et al.
Publicado: (2023)

CD19(+)CD24(hi)CD38(hi) regulatory B cells deficiency revealed severity and poor prognosis in patients with sepsis
por: Wang, Chunmei, et al.
Publicado: (2022)

Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis
por: Yang, Fengying, et al.
Publicado: (2019)

Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer
por: Zhao, Peiqi, et al.
Publicado: (2021)

Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis
por: Li, Yuegang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9bjjequi69js3e0ugs953242f